Vapotherm Inc. Stock Analysis VAPO

Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company is headquartered in Exeter, New Hampshire and currently employs 182 full-time employees. The company develops non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. The company is focused on the care of patients suffering from respiratory distress, whether associated with lung diseases, such as chronic obstructive pulmonary disease, congestive heart failure, pneumonia, asthma, and COVID-19 or other systemic conditions. Its device solutions are focused on High Velocity Nasal Insufflation, which delivers non-invasive ventilatory support to patients by providing heated, humidified, oxygenated air at high velocities through a small-bore nasal interface, and on closed loop control systems, such as its Oxygen Assist Module, designed to automatically maintain a patients pulse oxygen saturation levels within a specified range for a defined period of time. Its digital solutions are focused on remote patient monitoring, using algorithms to predict respiratory episodes.